Roxbury Financial’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$103K Sell
1,320
-1,632
-55% -$132K 0.08% 142
2026
Q1
$256K Buy
2,952
+16
+0.5% +$1.53K 0.23% 79
2025
Q4
$282K Sell
2,936
-9
-0.3% -$874 0.25% 70
2025
Q3
$280K Sell
2,945
-23
-0.8% -$2.11K 0.26% 70
2025
Q2
$259K Sell
2,968
-72
-2% -$6.11K 0.25% 73
2025
Q1
$280K Buy
3,040
+17
+0.6% +$1.52K 0.27% 71
2024
Q4
$262K Buy
+3,023
New +$262K 0.25% 73

Other funds holding MDT

Roxbury Financial's MDT Position: Q2 2026 in Review

Roxbury Financial reduced its Medtronic (MDT) stake by 55% in Q2 2026, selling an estimated $132K and leaving 1,320 shares worth $103K. The position accounts for 0.08% of the portfolio, ranked #142.

Roxbury Financial first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $282K in Q4 2025. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Roxbury Financial held 1,320 shares of Medtronic worth $103K as of Q2 2026.
  • Roxbury Financial sold 1,632 Medtronic shares in Q2 2026, an estimated $132K.
  • Medtronic made up 0.08% of Roxbury Financial's portfolio in Q2 2026, its #142 holding.
  • Roxbury Financial first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Roxbury Financial's Medtronic position peaked at $282K in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Roxbury Financial's 13F filing for Q2 2026, filed 1 Jul 2026.